| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 4.72 | -0.10 (-2.07%) | 4.19 - 6.95 | 1.0 million |
Market data as of 3:59PM 06/19/13. Quotes are delayed by at least 15 min.
Exelixis Announces Webcasts of Upcoming Investor Conference Presentations
06/05/2013 4:05 PM ET
Exelixis Presents COMETRIQ™ (cabozantinib) Clinical Trial Data in Patients with Progressive, Metastatic Medullary Thyroid Cancer
06/02/2013 9:00 AM ET
Exelixis Announces Presentation of Updated Phase 2 Data for Cabozantinib in Men with Heavily-Pretreated Metastatic Castration-Resistant Prostate Cancer
06/01/2013 9:00 AM ET